Collin Stabler

Collin Stabler's work experience begins in 2007 as an Intern at Long Island Jewish Medical Center, where they worked on novel applications for cartilage tissue engineering. In 2008, they worked as a Research Scientist at SBH Sciences before transitioning to a Research Assistant role at Drexel University in 2009. At Drexel University College of Medicine, they continued as a Research Assistant with a focus on isolation of Human Lung Mast Cells. In 2012, Stabler joined Temple University as a Research Assistant and continued until 2016. From 2016 to 2019, they worked as a Postdoctoral Fellow at the University of Pennsylvania School of Medicine. In 2018, Stabler began their journey at Exponent, starting as a Senior Associate and progressing to the positions of Senior Engineer, Managing Engineer, and currently holds the role of Senior Managing Engineer. Additionally, in 2022, they became an Adjunct Assistant Professor at Temple University College of Engineering.

Collin Stabler's education history begins with their high school diploma from Concord Carlisle Regional High School, which they obtained from 2000 to 2004. Collin then pursued a Bachelor of Science degree in Engineering from Hofstra University, attending from 2004 to 2008.

Continuing their education, Collin Stabler enrolled at the Drexel University School of Biomedical Engineering, Science and Health Systems from 2009 to 2013. However, they transferred to Temple University, where they ultimately completed their Doctor of Philosophy (PhD) degree in Bioengineering and Biomedical Engineering from 2013 to 2016.

After completing their PhD, Collin Stabler pursued a Postdoctoral Fellowship at the University of Pennsylvania School of Medicine from 2016 to 2018. During this fellowship, they specialized in Pulmonary Disease and Regeneration.

In addition to their educational achievements, Collin Stabler has obtained various certifications. Collin became a Professional Engineer (PE) certified by the Delaware Association of Professional Engineers in July 2021. Collin also obtained certification in ISO 10993 Series 1 Biocompatibility Testing, Evaluation and Risk Management from NAMSA in June 2021.

Overall, Collin Stabler has a strong academic background in engineering and biomedical fields, with notable expertise focused on pulmonary disease and regeneration through their postdoctoral fellowship.